Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 7:30 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2401–2424 of 3,418 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Routine Clear all

Conditions: Dialysis Fistula Creation, Endo-vascular AVFs
Interventions: Surgical AVF, Endo-vascular AVF; Procedure
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Renal Stones
Interventions: RetroPerc®; Device
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 2
States / cities: Tampa, Florida • Kansas City, Kansas

Conditions: Aneuploidy, Pregnancy Complications
Interventions: iPad-based decision aid, Genetic counseling appointment; Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 197 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Transfusion Dependent Thalassemia
Interventions: Mirasol Red Blood Cells (MIR RBCs), Reference Red Blood Cells (REF RBCs); Device
Lead sponsor: Terumo BCTbio; Industry
Eligibility: 12 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 4
States / cities: Oakland, California • Boston, Massachusetts • New York, New York + 1 more

Conditions: Infant, Premature, Nutrition, Enteral
Interventions: No aspiration of gastric contents, Routine aspiration of gastric contents; Procedure
Lead sponsor: University of Florida; Other
Eligibility: Up to 3 Days
Enrollment: 146 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Heart Failure; With Decompensation
Interventions: Remote Virtual Cardiology Program; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 73 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 5
States / cities: Panama City, Florida • Gainesville, Georgia • Raleigh, North Carolina + 2 more

Conditions: HIV Infections
Interventions: APRETUDE, Cabotegravir OLI; Drug
Lead sponsor: ViiV Healthcare; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 287 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 17
States / cities: Los Angeles, California • San Francisco, California • Washington D.C., District of Columbia + 14 more

Conditions: Sedentary Lifestyle, Diabetes Mellitus, Gestational
Interventions: Limit accumulation of sedentary time, Walk, Normal daily routine; Usual Care; Other
Lead sponsor: Iowa State University; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: Ames, Iowa

Conditions: Periprosthetic Infection, Oral Antibiotics, Revision Total Shoulder Arthroplasty
Interventions: Doxycycline 100 MG Oral Tablet; Drug
Lead sponsor: Rothman Institute Orthopaedics; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Recurrent Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer
Interventions: diffusion-weighted magnetic resonance imaging, 4-dimensional computed tomography, fludeoxyglucose F 18, FDG-PET; Device · Radiation
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 21 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Venous Leg Ulcer (VLU)
Interventions: Omeza OCM™ Wound Matrix, Routine Care; Device · Procedure
Lead sponsor: Omeza, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 254 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Lake Success, New York

Conditions: Osteoarthritis
Interventions: Activity Strategy Training, Education; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 62 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Liver Cancer, Cancer of the Liver
Interventions: 4Dimensional Phase Contrast Magnetic Resonance Angiography, Portal vein embolization; Device · Procedure
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Histological or Cytological Diagnosis of Pancreatic Carcinoma
Interventions: Radiation therapy; Device
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: HIV
Interventions: "Smart" home-based test for HIV, Home-based testing only, Reminder letters for clinic-based testing; Behavioral
Lead sponsor: Brown University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 65 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: DCIS, Stage 0 Breast Cancer, Ductal Breast Carcinoma In Situ
Interventions: Treatment recommendation surveys, 7-gene biosignature; Other · Device
Lead sponsor: PreludeDx; Industry
Eligibility: 30 Years to 85 Years · Female only
Enrollment: 3,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2036
U.S. locations: 30
States / cities: Scottsdale, Arizona • La Jolla, California • San Mateo, California + 25 more

Conditions: Hypoxia, Apnea, Hypotension, Hypopnea
Interventions: Capnographic Monitoring; Diagnostic Test
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 452 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Independence, Ohio

Conditions: Colorectal Cancer Screening
Interventions: mPATH-CRC, Usual Care (Control); Other
Lead sponsor: Digital Health Navigation Solutions, Inc; Industry
Eligibility: 45 Years to 74 Years
Enrollment: 6,500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: Rome, Georgia • Winston-Salem, North Carolina

Conditions: Hepatocellular Carcinoma
Interventions: ICG, Optical molecular imaging; Biological · Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cancer, Cancer, Treatment-Related
Interventions: ImmunOncoTool Condition; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Low Blood Pressure, Delirium, Critical Illness
Interventions: sedation awakening trial; Other
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Chronic Lymphocytic Leukemia
Interventions: Idelalisib, Ofatumumab; Drug
Lead sponsor: Gilead Sciences; Industry
Eligibility: 18 Years and older
Enrollment: 261 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2018
U.S. locations: 24
States / cities: Duarte, California • Fresno, California • San Diego, California + 21 more

Conditions: Heart Failure
Interventions: Family SWaP intervention, usual care; Behavioral
Lead sponsor: Misook L. Chung; Other
Eligibility: 21 Years to 90 Years
Enrollment: 316 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Autism Spectrum Disorder
Interventions: Treatment as Usual, Early Social Interaction Mobile Coaching (ESI-MC); Behavioral
Lead sponsor: Florida State University; Other
Eligibility: 15 Months to 20 Months
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 8
States / cities: Los Angeles, California • Tallahassee, Florida • Atlanta, Georgia + 5 more

Search by objective public record fields.

Endovascular vs Surgical Arteriovenous Fistula Outcomes

RETRO Study (RETrograde Renal Access Outcomes)

Use of a Novel Computerized Decision Aid for Prenatal Aneuploidy Screening

Efficacy and Safety of RBCs Derived From Mirasol-treated Whole Blood in Patients Requiring Chronic Transfusion (PRAISE)

Aspiration of Residual Gastric Contents

Evaluation Of A Virtual Cardiology Program To Improve Outcomes After Acute Decompensated Heart Failure

A Study Evaluating Implementation Strategies for the Delivery of Cabotegravir in Low and High-Volume PrEP Site in the United States

The Blossom Project: "BlossomUP" Methods to Decrease Sedentary Time in Pregnancy

Prospective Evaluation of Oral Antibiotics for Treatment of Shoulder PJI

Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung Cancer

OCM™ Treatment With Routine Care in Venous Leg Ulcers Compared to Routine Care Treatment Alone.

Exercise Plus Activity Strategy Training for Osteoarthritis

4D Phase Contrast MR: Hypertrophy in Liver Cancer

A Pilot Study to Evaluate Radiotherapy-Induced Anti-Tumor Immunity in Metastatic Carcinoma of the Pancreas

Evaluating a Real-Time, Remote Monitoring System for Home-Based HIV Testing

The PREDICT Registry:

Use of Capnography in EGD and Colonoscopy With Moderate Sedation.

Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening

A Pilot Study of Optical Molecular Imaging for Percutaneous Biopsy of Hepatocellular Carcinoma Using Indocyanine Green

Development of ImmunOncoTool

Vasopressor SAT Study

Efficacy and Safety of Idelalisib in Combination With Ofatumumab for Previously Treated Chronic Lymphocytic Leukemia

Effects of Family Sodium Watcher Program on Outcomes in Heart Failure Patient-Family Caregiver Dyads

Effectiveness Trial of Mobile ESI for Toddlers With Autism Identified by Early Screening in Primary Care